Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 16(12): 1646-50, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23161036

RESUMEN

BACKGROUND: Peripheral arterial disease (PAD) is a strong marker of cardiovascular disease but remains an under-diagnosed problem. Moreover, PAD frequently leads to foot problems requiring particular care and surveillance. AIM: The aims of this study were (1) to determine the prevalence of undiagnosed PAD in a cohort of asymptomatic subjects referred to a podiatric clinic and (2) to evaluate whether a four-item form assessing medical history for the presence of cardiovascular risk factors could identify subjects at high risk for asymptomatic PAD. PATIENTS AND METHODS: This study included 717 consecutive subjects (121 males, age 50.9±13.9 y) referring to a podiatric clinic who were asymptomatic for PAD and free of cardiovascular disease. The ankle brachial index (ABI) was measured in all subjects. Each subject also completed a self-administered form to identify cardiovascular risk factors. RESULTS: Among the entire cohort, the prevalence of PAD was 8.3% in males and 1.2% in females. Three subgroups were identified according to the number of risk factors reported (no risk factors, one risk factor, and two or more risk factors), and the prevalence of PAD differed between each subgroup (0.2%, 3.2%, and 18.9%, respectively; p < 0.001). CONCLUSIONS: In an unselected cohort of subjects referring to a podiatric clinic, who were asymptomatic for PAD and free from cardiovascular diseases, a remarkable prevalence of PAD was found among subjects reporting a minimum of two cardiovascular risk factors. In a podiatric setting, screening with a self-administered form for the presence of cardiovascular risk factors might lead to an early diagnosis of PAD.


Asunto(s)
Tamizaje Masivo/métodos , Enfermedad Arterial Periférica/diagnóstico , Enfermedad Arterial Periférica/epidemiología , Podiatría/métodos , Índice Tobillo Braquial/estadística & datos numéricos , Enfermedades Cardiovasculares/epidemiología , Femenino , Humanos , Italia/epidemiología , Masculino , Tamizaje Masivo/estadística & datos numéricos , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Autoinforme
2.
AJNR Am J Neuroradiol ; 32(5): 938-46, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21474626

RESUMEN

BACKGROUND AND PURPOSE: CCSVI was recently described in patients with MS. CCSVI is diagnosed noninvasively by Doppler sonography and invasively by catheter venography. We assessed the role of conventional MRV for the detection of IJV anomalies in patients with MS diagnosed with CCSVI and in healthy controls who underwent MRV and Doppler sonography examinations during 6 months. MATERIALS AND METHODS: Ten patients with MS underwent TOF, TRICKS, Doppler sonography, and catheter venography at baseline. They were treated at baseline with percutaneous angioplasty and re-evaluated 6 months' posttreatment with MRV and Doppler sonography. In addition, 6 healthy controls underwent a baseline and a 6-month follow-up evaluation by Doppler sonography and MRV. RESULTS: At baseline, the sensitivity, specificity, PPV, and NPV of Doppler sonography for detecting IJV abnormalities relative to catheter venography in patients with MS were calculated, respectively, at 82%, 100%, 99%, and 95%. The figures were 99%, 33%, 33%, 99% for TOF and 99%, 39%, 35%, and 99% for TRICKS. Venous anomalies included the annulus, septum, membrane, and malformed valve. No agreement was found between TOF and catheter venography in 70% of patients with MS and between TRICKS and catheter venography in 60% of patients with MS. At follow-up, 50% of the patients with MS presented with abnormalities on Doppler sonography but only 30% were diagnosed with restenosis. CONCLUSIONS: Conventional MRV has limited value for assessing IJV anomalies for both diagnostic and posttreatment purposes.


Asunto(s)
Venas Yugulares/patología , Angiografía por Resonancia Magnética/métodos , Esclerosis Múltiple/complicaciones , Esclerosis Múltiple/patología , Insuficiencia Venosa/patología , Adulto , Anciano , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Proyectos Piloto , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Adulto Joven
3.
J Sports Med Phys Fitness ; 51(1): 153-9, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21297575

RESUMEN

AIM: Substances and methods used to increase oxygen blood transport and physical performance can be detected in the blood, but the screening of the athletes to be tested remains a critical issue for the International Federations. This project, AR.I.E.T.T.A., aimed to develop a software capable of analysing athletes' hematological and performance profiles to detect abnormal patterns. METHODS: One-hundred eighty athletes belonging to the International Biathlon Union gave written informed consent to have their hematological data, previously collected according to anti-doping rules, used to develop the AR.I.E.T.T.A. software. RESULTS: Software was developed with the included sections: 1) log-in; 2) data-entry: where data are loaded, stored and grouped; 3) analysis: where data are analysed, validated scores are calculated, and parameters are simultaneously displayed as statistics, tables and graphs, and individual or subpopulation profiles; 4) screening: where an immediate evaluation of the risk score of the present sample and/or the athlete under study is obtained. The sample risk score or AR.I.E.T.T.A. score is calculated by a simple computational system combining different parameters (absolute values and intra-individual variations) considered concurrently. The AR.I.E.T.T.A. score is obtained by the sum of the deviation units derived from each parameter, considering the shift of the present value from the reference values, based on the number of standard deviations. CONCLUSION: AR.I.E.T.T.A. enables a quick evaluation of blood results assisting surveillance programs and perform timely target testing controls on athletes by the International Federations. Future studies aiming to validate the AR.I.E.T.T.A. score and improve the diagnostic accuracy will improve the system.


Asunto(s)
Inteligencia Artificial , Rendimiento Atlético/fisiología , Rendimiento Atlético/estadística & datos numéricos , Doping en los Deportes/prevención & control , Pruebas Hematológicas/estadística & datos numéricos , Femenino , Pruebas Hematológicas/métodos , Humanos , Masculino , Programas Informáticos , Deportes , Análisis y Desempeño de Tareas
4.
Int Angiol ; 29(2): 121-6, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20351668

RESUMEN

AIM: Chronic cerebrospinal venous insufficiency (CCSVI) is a syndrome described in multiple sclerosis (MS) patients, characterized by stenosis of the main extracranial veins with hampered cerebral venous outflow. In the original description echo-colour Doppler demonstrated to be an ideal non invasive tool for screening CCSVI patients, but the reproducibility was not assessed. Aim of this study is to assess the variability coefficient between trained and in not trained echo-colour Doppler operators. METHODS: Thirty-six (36) subjects, matched for age and gender, were subset in 3 groups (group A, 12 healthy controls, HC; group B, 12 multiple sclerosis patients, MS; group C, 12 patients with other neurological disease, OND) underwent echo-colour Doppler screening for CCSVI according to an original protocol previously described. The inter observer variability rate was assessed by comparing respectively trained vs not trained operators, and trained vs trained operators, by using the same echo-colour Doppler equipment. In addition, by scanning 15 subjects after one month from the first session, intra observer coefficient was also assessed in trained operator. RESULTS: The inter observer variability rate between trained and not trained echo-colour Doppler operators, were not completely satisfactory (K coefficient 0.47 95% CI 0.27-0.68). To the contrary the inter observer agreement between trained operators was much more reliable (K coefficient 0.80 95% CI 0.59-1.01). Finally, the intra observer variability rate in trained operators was 0.93, (95% CI 0.80-1.06) confirming a highly satisfactory agreement. CONCLUSION: Echo-colour Doppler is a powerful, non-invasive and reproducible tool for screening CCSVI-MS but it needs special training.


Asunto(s)
Venas Yugulares/diagnóstico por imagen , Esclerosis Múltiple/diagnóstico por imagen , Médula Espinal/irrigación sanguínea , Ultrasonografía Doppler en Color , Insuficiencia Venosa/diagnóstico por imagen , Adulto , Estudios de Casos y Controles , Enfermedad Crónica , Competencia Clínica , Circulación Colateral , Constricción Patológica , Femenino , Hemodinámica , Humanos , Venas Yugulares/anomalías , Venas Yugulares/fisiopatología , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/fisiopatología , Variaciones Dependientes del Observador , Valor Predictivo de las Pruebas , Flujo Sanguíneo Regional , Reproducibilidad de los Resultados , Insuficiencia Venosa/fisiopatología , Adulto Joven
5.
Int Angiol ; 29(2): 127-39, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20351669

RESUMEN

AIM: Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of primary veins outside the skull that restrict normal outflow of blood from the brain. CCSVI was recently described as highly prevalent in patients with multiple sclerosis (MS), and can be non-invasively diagnosed by Doppler sonography (DS) and invasively by selective venography (SV). The aim of this paper was to investigate the value of neck magnetic resonance venography (MRV) for the diagnosis of CCSVI compared to DS and SV in patients with MS and in healthy controls (HC). METHODS: Ten MS patients and 7 HC underwent DS, 2D-Time-Of-Flight venography (TOF) and 3D-Time Resolved Imaging of Contrast Kinetics angiography (TRICKS). MS patients also underwent SV. The internal jugular veins (IJVs) and the vertebral veins (VVs) were assessed by both MRV sequences, and the findings were validated against SV and DS. SV has been considered the diagnostic gold standard for MS patients. RESULTS: All MS patients and none of the HC presented CCSVI, according to the DS criteria. This was confirmed by SV. For CCSVI diagnosis, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, whereas the figures were 40%, 85%, 58%, 80% and 50% for 3D-TRICKS, and 30%, 85%, 52%, 75% and 46% for 2D-TOF in the IJVs. In MS patients, compared to SV, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, 75%, 95%, 94% and 100%, whereas the figures were 31%, 100%, 45%, 100% and 26% for 3D-TRICKS and 25%, 100%, 40%, 100% and 25% for 2D-TOF in the IJVs. CONCLUSION: The use of MRV for diagnosis of CCSVI in MS patients has limited value, and the findings should be interpreted with caution and confirmed by other imaging techniques such as DS and SV.


Asunto(s)
Venas Yugulares , Angiografía por Resonancia Magnética , Esclerosis Múltiple Recurrente-Remitente/diagnóstico , Flebografía/métodos , Médula Espinal/irrigación sanguínea , Ultrasonografía Doppler , Insuficiencia Venosa/diagnóstico , Adulto , Estudios Transversales , Femenino , Humanos , Venas Yugulares/anomalías , Venas Yugulares/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Esclerosis Múltiple Recurrente-Remitente/fisiopatología , Proyectos Piloto , Valor Predictivo de las Pruebas , Flujo Sanguíneo Regional , Sensibilidad y Especificidad , Insuficiencia Venosa/fisiopatología
6.
Int Angiol ; 29(2): 140-8, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20351670

RESUMEN

AIM: We previously reported unexpectedly robust associations between vascular haemodynamic (VH) anomalies in the principal extracranial cerebral veins, causing chronic cerebrospinal venous insufficiency (CCSVI), and multiple sclerosis (MS). Aim of this study was to investigate the relationship between the VH changes and MRI measures of MS disease severity in a cross sectional survey. METHODS: The number of anomalous VH criteria were measured using an echo-color Doppler, whereas CSF flow, atrophy and lesion measures were obtained from quantitative magnetic resonance imaging (MRI) analysis in sixteen consecutive relapsing-remitting MS patients, (mean age: 36.1+/-SD 7.3 years, disease duration: 7.5+/-1.9 years and median EDSS: 2.5) and in 8 healthy controls (HC) with similar age and sex distributions. RESULTS: All 16 MS patients investigated and none of the HCs met the VH criteria for CCSVI (P<0.0001). MS patients showed significantly lower net CSF flow compared to the HC (P=0.038) that was associated with number of anomalous VH criteria present (r=0.79, P<0.001). Moreover, increases in the number of anomalous VH criteria present were negatively associated with lower whole brain volume (Spearman R=-0.5, P=0.05). CONCLUSION: VH changes occur more frequently in MS patients than controls. Altered VH is associated with abnormal CSF flow dynamics and decreased brain volume.


Asunto(s)
Vena Ácigos , Encéfalo/patología , Venas Yugulares , Imagen por Resonancia Magnética , Esclerosis Múltiple Recurrente-Remitente/diagnóstico , Médula Espinal/irrigación sanguínea , Ultrasonografía Doppler en Color , Insuficiencia Venosa/diagnóstico , Adulto , Atrofia , Vena Ácigos/anomalías , Vena Ácigos/diagnóstico por imagen , Vena Ácigos/fisiopatología , Venas Cerebrales/anomalías , Venas Cerebrales/diagnóstico por imagen , Venas Cerebrales/fisiopatología , Circulación Cerebrovascular , Constricción Patológica , Estudios Transversales , Humanos , Venas Yugulares/anomalías , Venas Yugulares/diagnóstico por imagen , Venas Yugulares/fisiopatología , Esclerosis Múltiple Recurrente-Remitente/líquido cefalorraquídeo , Esclerosis Múltiple Recurrente-Remitente/fisiopatología , Tamaño de los Órganos , Proyectos Piloto , Flujo Sanguíneo Regional , Insuficiencia Venosa/líquido cefalorraquídeo , Insuficiencia Venosa/fisiopatología
7.
Int Angiol ; 29(2): 158-75, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20351672

RESUMEN

AIM: Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular phenomenon recently described in multiple sclerosis (MS) that is characterized by stenoses affecting the main extracranial venous outflow pathways and by a high rate of cerebral venous reflux that may lead to increased iron deposition in the brain. Aim of this study was to investigate the relationship between CCSVI and iron deposition in the brain of MS patients by correlating venous hemodynamic (VH) parameters and iron concentration in deep-gray matter structures and lesions, as measured by susceptibility-weighted imaging (SWI), and to preliminarily define the relationship between iron measures and clinical and other magnetic resonance imaging (MRI) outcomes. METHODS: Sixteen (16) consecutive relapsing-remitting MS patients and 8 age- and sex-matched healthy controls (HC) were scanned on a GE 3T scanner, using SWI. RESULTS: All 16 MS patients fulfilled the diagnosis of CCSVI (median VH=4), compared to none of the HC. In MS patients, the higher iron concentration in the pulvinar nucleus of the thalamus, thalamus, globus pallidus, and hippocampus was related to a higher number of VH criteria (P<0.05). There was also a significant association between a higher number of VH criteria and higher iron concentration of overlapping T2 (r=-0.64, P=0.007) and T1 (r=-0.56, P=0.023) phase lesions. Iron concentration measures were related to longer disease duration and increased disability as measured by EDSS and MSFC, and to increased MRI lesion burden and decreased brain volume. CONCLUSION: The findings from this pilot study suggest that CCSVI may be an important mechanism related to iron deposition in the brain parenchyma of MS patients. In turn, iron deposition, as measured by SWI, is a modest-to-strong predictor of disability progression, lesion volume accumulation and atrophy development in patients with MS.


Asunto(s)
Encéfalo/metabolismo , Hierro/análisis , Venas Yugulares/patología , Imagen por Resonancia Magnética , Esclerosis Múltiple Recurrente-Remitente/diagnóstico , Médula Espinal/irrigación sanguínea , Insuficiencia Venosa/diagnóstico , Adulto , Atrofia , Encéfalo/patología , Estudios de Casos y Controles , Circulación Cerebrovascular , Enfermedad Crónica , Constricción Patológica , Evaluación de la Discapacidad , Femenino , Humanos , Italia , Venas Yugulares/fisiopatología , Masculino , Esclerosis Múltiple Recurrente-Remitente/metabolismo , Esclerosis Múltiple Recurrente-Remitente/patología , Esclerosis Múltiple Recurrente-Remitente/fisiopatología , New York , Proyectos Piloto , Valor Predictivo de las Pruebas , Flujo Sanguíneo Regional , Índice de Severidad de la Enfermedad , Insuficiencia Venosa/metabolismo , Insuficiencia Venosa/patología , Insuficiencia Venosa/fisiopatología
8.
Int Angiol ; 29(2): 176-82, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20351673

RESUMEN

AIM: Chronic fatigue (CF) severely affects patients with multiple sclerosis (MS), but its pathogenesis remains elusive and the effectiveness of available treatments is modest. We aimed to evaluate the effect on CF of the balloon dilatation of stenosing lesions affecting the main extracranial veins configuring the chronic cerebrospinal venous insufficiency (CCSVI), a condition strongly associated with MS. METHODS: Thirty-one MS consecutive patients (16 males, age 46.2+/-9.4 years) with associated CCSVI and CF underwent the endovascular procedure. Fatigue was assessed using the Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS) at baseline (T0) and one (T1), six (T6) and twelve (T12) months after the procedure. In ambulatory patients (N.=28), mobility was evaluated using the 6-min walking test at T0 and T1. RESULTS: and MFIS scores significantly improved from preoperative values, and the positive trend was maintained at one year (FSS: T0=5.1+/-1.0 to T12=3.5+/-1.8, P<0.001; MFIS-total score: T0=34.9+/-14.8 to T12=22.5+/-13.7, P<0.001; MFIS-Physical subscale: T0=21.2+/-8.0 to T12=13.5+/-9.7 P<0.001; MFIS-Cognitive subscale: T0=9.2+/-9.5 to T12=6.0+/-6.3, P=0.03; MFIS-Psychosocial subscale: T0=4.5+/-2.1 to T12=2.5+/-2.1, P<0.001). Six-min walking distance (6MWD) at T1 improved significantly (332+/-190m to 378+/-200m, P=0.0002). In addition, an inverted correlation between 6MWD and MFIS-physical subscale variations was found in the subgroup of patients (N.=8) with no lower limb motor impairment (r=-0.74, P=0.035). CONCLUSION: The reestablishment of cerebral venous return dramatically reduced CF perception in a group of MS patients with associated CCSVI, suggesting that CF is likely the symptom of CCSVI.


Asunto(s)
Angioplastia de Balón , Vena Ácigos , Fatiga/etiología , Venas Yugulares , Esclerosis Múltiple/complicaciones , Médula Espinal/irrigación sanguínea , Insuficiencia Venosa/terapia , Adulto , Vena Ácigos/diagnóstico por imagen , Vena Ácigos/fisiopatología , Enfermedad Crónica , Constricción Patológica , Evaluación de la Discapacidad , Fatiga/diagnóstico , Fatiga/fisiopatología , Femenino , Humanos , Venas Yugulares/diagnóstico por imagen , Venas Yugulares/fisiopatología , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/diagnóstico , Esclerosis Múltiple/fisiopatología , Flebografía , Proyectos Piloto , Flujo Sanguíneo Regional , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía Doppler en Color , Grado de Desobstrucción Vascular , Insuficiencia Venosa/complicaciones , Insuficiencia Venosa/diagnóstico , Insuficiencia Venosa/fisiopatología
9.
Funct Neurol ; 24(3): 133-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20018140

RESUMEN

Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular picture that shows a strong association with multiple sclerosis (MS). The aim of this study was to investigate the relationship between a Doppler cerebral venous hemodynamic insufficiency severity score (VHISS) and cerebrospinal fluid (CSF) flow dynamics in 16 patients presenting with CCSVI and relapsing-remitting MS (CCSVI-MS) and in eight healthy controls (HCs). The two groups (patients and controls) were evaluated using validated echo-Doppler and advanced 3T-MRI CSF flow measures. Compared with the HCs, the CCSVI-MS patients showed a significantly lower net CSF flow (p=0.027) which was highly associated with the VHISS (r=0.8280, r2=0.6855; p=0.0001). This study demonstrates that venous outflow disturbances in the form of CCSVI significantly impact on CSF pathophysiology in patients with MS.


Asunto(s)
Líquido Cefalorraquídeo/fisiología , Circulación Cerebrovascular/fisiología , Trastornos Cerebrovasculares/complicaciones , Hemodinámica , Esclerosis Múltiple Recurrente-Remitente/complicaciones , Insuficiencia Venosa/complicaciones , Adulto , Encéfalo/irrigación sanguínea , Estudios de Casos y Controles , Presión del Líquido Cefalorraquídeo , Trastornos Cerebrovasculares/líquido cefalorraquídeo , Enfermedad Crónica , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Análisis por Apareamiento , Esclerosis Múltiple Recurrente-Remitente/líquido cefalorraquídeo , Proyectos Piloto , Valores de Referencia , Flujo Sanguíneo Regional , Índice de Severidad de la Enfermedad , Método Simple Ciego , Médula Espinal/irrigación sanguínea , Ultrasonografía Doppler en Color , Ultrasonografía Doppler Transcraneal , Insuficiencia Venosa/líquido cefalorraquídeo
10.
Eur J Vasc Endovasc Surg ; 38(4): 441-8, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19625198

RESUMEN

OBJECTIVES: Near-Infrared Spectroscopy (NIRS), suitable for dynamic measurements, is not routinely used for peripheral arterial disease (PAD). We propose a dynamic NIRS-based measurement to quantify variations in muscle metabolism in PAD. METHOD: Sixty-seven consecutive PAD patients (males=56, age 71.6+/-8.7 years) and 28 healthy subjects (males=12, age 30.4+/-11.9 years) were studied. An echo-colour Doppler (ECD) was performed and the ankle-brachial index (ABI) was calculated. Participants performed an incremental treadmill test with NIRS probes on the gastrocnemius. Variations in oxygenated (HbO(2)), deoxygenated (HHb), total (tHb=HbO(2)+HHb), and differential (dHb=HbO(2)-HHb) haemoglobin were recorded and quantified as area-under-curve (AUC) within the range 1.7-3.0 km h(-1). Heart rate was recorded, and the number of beats in the same interval was calculated (dHr). RESULTS: O(2)Hb(AUC), HHb(AUC) and dHb(AUC) differed between diseased and non-diseased legs (P<0.0001) and exhibited different patterns related to PAD severity according to the ABI value. A compensatory heart rate increase was observed in PAD patients. Compared with the ECD positivity for occlusions/stenoses or multiple plaques, only the receiver-operating characteristic (ROC) analysis of dHb(AUC) (area=0.932, P<0.0001) showed a sensitivity/specificity of 87.6/93.4 for values

Asunto(s)
Prueba de Esfuerzo , Hemoglobinas/metabolismo , Claudicación Intermitente/etiología , Músculo Esquelético/metabolismo , Oxihemoglobinas/metabolismo , Enfermedades Vasculares Periféricas/diagnóstico , Espectroscopía Infrarroja Corta , Anciano , Anciano de 80 o más Años , Tobillo/irrigación sanguínea , Biomarcadores/sangre , Presión Sanguínea , Arteria Braquial/fisiopatología , Estudios de Casos y Controles , Femenino , Frecuencia Cardíaca , Humanos , Claudicación Intermitente/sangre , Claudicación Intermitente/fisiopatología , Masculino , Enfermedades Vasculares Periféricas/sangre , Enfermedades Vasculares Periféricas/complicaciones , Enfermedades Vasculares Periféricas/fisiopatología , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Ultrasonografía Doppler en Color
11.
J Sports Med Phys Fitness ; 49(2): 208-13, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19528901

RESUMEN

AIM: Biathlon is a sport that combines cross-country skiing with rifle shooting. There is no well-described model of performance in this multi-sport event. This study aimed to identify the parameters influencing biathlon performance. In addition, the study aimed to search for a relationship between performance and measured blood parameters and to determine whether higher hemoglobin concentration [Hb] was associated with improved performance. METHODS: Eighty-three male biathletes underwent pre-competition blood sampling in selected World Cup competitions. For all athletes (N=83) and for a subgroup of top-athletes (N=37), performance parameters identified were related to final standings by univariate and multiple regression analyses and, subsequently, to blood parameters measured on the same day. In athletes tested twice with different [Hb], performance corresponding to competitions with lower and higher [Hb] was compared. RESULTS: Among the parameters considered, the percent variation for both groups in best skiing time and percent of missed targets were independent determinants of performance (R2=0.853, 0.834, respectively) and were not correlated to blood parameters. In athletes with two samples, despite significantly different (Hb), no corresponding changes in performance were observed. CONCLUSIONS: In this study, the determinants of biathlon performance were identified. A relationship between measured blood parameters was not found, and the individual (Hb) variations observed were not associated with improved performance.


Asunto(s)
Rendimiento Atlético/fisiología , Hemoglobinas/metabolismo , Esquí/fisiología , Adolescente , Adulto , Humanos , Masculino , Modelos Biológicos , Adulto Joven
12.
J Int Med Res ; 37(2): 534-40, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19383248

RESUMEN

Haemodialysis patients have few endothelial progenitor cells (EPCs) and an unfavourable cardiovascular outcome. The effects on peripheral blood CD34(+) cells and EPCs of a 6-month walking exercise programme were studied. Thirty dialysis patients (20 males, age 67 +/- 12 years) were prescribed exercise (two daily 10-min home walking sessions at moderate intensity, group E, n = 16) or not prescribed exercise (control, group C, n = 14). On entry and after 6 months peripheral blood CD34(+) cells, EPCs (assessed as CD34(+) cells co-expressing AC133 and vascular endothelial growth factor receptor 2 [VEGFR2], and as endothelial colony-forming units [e-CFU]) and exercise capacity (6-min walking distance, 6MWD) were evaluated. In group E, 6MWD and e-CFU increased significantly during the study period, with no significant changes in CD34(+) or CD34(+) AC133(+) VEGFR2(+) cell numbers. The change in e-CFU was directly and significantly correlated to patient-reported training load. Group C showed no significant change in any variable. In haemodialysis patients, moderate-intensity exercise selectively increased the number of e-CFU.


Asunto(s)
Células Endoteliales/citología , Ejercicio Físico/fisiología , Diálisis Renal , Células Madre/citología , Anciano , Ensayo de Unidades Formadoras de Colonias , Femenino , Humanos , Masculino , Caminata/fisiología
13.
Curr Drug Targets ; 10(4): 344-55, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19355859

RESUMEN

Hypertriglyceridaemia is a common dyslipidaemia encountered in clinical practice. People with hypertriglyceridaemia are frequently obese, insulin-resistant, hypertensive or diabetic, all of which are risk factors for cardiovascular diseases. Hypertriglyceridaemia also contributes to metabolic syndrome, in which an atherogenic diet, sedentary lifestyle, overweight/obesity and genetic factors interact. A multi-factorial intervention for all risk factors is necessary, including weight reduction, dietary modification and increased physical exercise. This review focuses on the influence of diet, sedentary lifestyle and negative habits (such as excessive alcohol intake, smoking and drug addiction) on hypertriglyceridaemia as well as the effects of lifestyle change.


Asunto(s)
Hipertrigliceridemia/terapia , Estilo de Vida , Conducta de Reducción del Riesgo , Animales , Ejercicio Físico/fisiología , Conducta Alimentaria/fisiología , Conductas Relacionadas con la Salud , Humanos , Hipertrigliceridemia/sangre , Hipertrigliceridemia/complicaciones , Obesidad/sangre , Obesidad/complicaciones , Obesidad/terapia
14.
J Neurol Neurosurg Psychiatry ; 80(4): 392-9, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19060024

RESUMEN

BACKGROUND: The extracranial venous outflow routes in clinically defined multiple sclerosis (CDMS) have not previously been investigated. METHODS: Sixty-five patients affected by CDMS, and 235 controls composed, respectively, of healthy subjects, healthy subjects older than CDMS patients, patients affected by other neurological diseases and older controls not affected by neurological diseases but scheduled for venography (HAV-C) blindly underwent a combined transcranial and extracranial colour-Doppler high-resolution examination (TCCS-ECD) aimed at detecting at least two of five parameters of anomalous venous outflow. According to the TCCS-ECD screening, patients and HAV-C further underwent selective venography of the azygous and jugular venous system with venous pressure measurement. RESULTS: CDMS and TCCS-ECD venous outflow anomalies were dramatically associated (OR 43, 95% CI 29 to 65, p<0.0001). Subsequently, venography demonstrated in CDMS, and not in controls, the presence of multiple severe extracranial stenosis, affecting the principal cerebrospinal venous segments; this provides a picture of chronic cerebrospinal venous insufficiency (CCSVI) with four different patterns of distribution of stenosis and substitute circle. Moreover, relapsing-remitting and secondary progressive courses were associated with CCSVI patterns significantly different from those of primary progressive (p<0.0001). Finally, the pressure gradient measured across the venous stenosies was slightly but significantly higher. CONCLUSION: CDMS is strongly associated with CCSVI, a scenario that has not previously been described, characterised by abnormal venous haemodynamics determined by extracranial multiple venous strictures of unknown origin. The location of venous obstructions plays a key role in determining the clinical course of the disease.


Asunto(s)
Trastornos Cerebrovasculares/etiología , Esclerosis Múltiple/complicaciones , Enfermedades de la Médula Espinal/etiología , Columna Vertebral/irrigación sanguínea , Adulto , Trastornos Cerebrovasculares/diagnóstico por imagen , Trastornos Cerebrovasculares/fisiopatología , Enfermedad Crónica , Constricción Patológica , Progresión de la Enfermedad , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/diagnóstico por imagen , Esclerosis Múltiple/fisiopatología , Esclerosis Múltiple Recurrente-Remitente/diagnóstico por imagen , Esclerosis Múltiple Recurrente-Remitente/fisiopatología , Postura/fisiología , Flujo Sanguíneo Regional/fisiología , Enfermedades de la Médula Espinal/diagnóstico por imagen , Enfermedades de la Médula Espinal/fisiopatología , Columna Vertebral/diagnóstico por imagen , Posición Supina/fisiología , Ultrasonografía Doppler en Color , Ultrasonografía Doppler Transcraneal
15.
Int J Sports Med ; 28(5): 368-73, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17024634

RESUMEN

Mobilization of circulating endothelial progenitor cells (EPCs) is increased after acute exercise and training. This study aims to evaluate whether, in a low performance population, EPC levels may be related to exercise capacity in steady state conditions. Study population consisted of sixteen hemodialysis patients. The distance walked in the 6-minute walking test (6 MWD) and the maximal speed attained in an incremental treadmill test were used to assess the exercise capacity. Physical functioning was measured by the scale on the SF36 questionnaire. Quantification of peripheral blood CD34(+) cells and enumeration of EPCs, assessed as CD34(+) cells coexpressing AC 133 and vascular endothelial growth factor receptor-2, were performed. Hemoglobin concentration, white blood cells, high-sensitivity C-reactive protein, total cholesterol, and triglycerides were measured. Statistical analysis examined the relationship between blood progenitors cells versus performance parameters, laboratory parameters, age, body mass index, hemodialysis duration, and erythropoietin therapy. Univariate analysis revealed a significant association between percentage values of EPC and performance parameters only: 6 MWD (r=0.720; p=0.0017), maximal treadmill speed (r=0.721; p=0.0016), and physical functioning score (r=0.506; p=0.0453). A similar statistical association between EPC absolute values and performance parameters was found. No correlation between CD34 (+) and any parameter under study was observed. Multivariate analysis indicated 6 MWD as the most significant independent factor associated with EPC level. EPC percentage value was significantly lower (p=0.0087) in the worse (6 MWD < 300 m, n=8) than in the better performing group (6 MWD > 300 m, n=8). In a group of renal patients, mobilization of EPCs was related to the degree of exercise capacity, suggesting a possible connection with the cardiovascular risk in low performance populations limited by chronic diseases.


Asunto(s)
Células Endoteliales/fisiología , Tolerancia al Ejercicio/fisiología , Fallo Renal Crónico/fisiopatología , Diálisis Renal , Células Madre/fisiología , Anciano , Antígenos CD34 , Recuento de Células , Prueba de Esfuerzo , Femenino , Humanos , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad
18.
Eur J Vasc Endovasc Surg ; 28(3): 303-9, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15288635

RESUMEN

OBJECTIVE: To evaluate a new treadmill test, determining pain threshold speed (PTS) for use in assessment and measuring rehabilitation of patients with intermittent claudication. METHODS AND DESIGN: Twenty-nine patients with claudication were evaluated, and the ankle-brachial index (ABI) was assessed. PTS was determined with a treadmill protocol based on level walking, low starting speed, and progressive increments at a predetermined distance up to the onset of pain. Repeatability and equivalence with a time-based protocol were verified. PTS was compared to pain-free walking distance, 6-minute walking distance, and ABI. RESULTS: PTS was measured in all patients (3.6+/-1.1 km/h). Repeatability and equivalence between established tests were demonstrated. PTS showed a significant correlation with pain-free walking distance (r=0.833; P=0.0001), with 6-minute walking distance (r=0.724; P=0.005), and with ABI in the more ischemic limb (r=0.641; P=0.0001). CONCLUSIONS: PTS is a reliable parameter that correlates well with other established measures. It is useful for determining the degree of functional handicap and for designing and guiding rehabilitation protocols.


Asunto(s)
Prueba de Esfuerzo/instrumentación , Claudicación Intermitente/diagnóstico , Anciano , Diseño de Equipo , Estudios de Factibilidad , Femenino , Humanos , Masculino , Umbral del Dolor , Reproducibilidad de los Resultados , Factores de Tiempo
19.
Int Angiol ; 23(4): 379-87, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15767984

RESUMEN

AIM: To verify the effectiveness of a 120 day home-based program guided by the pain threshold speed (PTS). METHODS: Twenty-nine patients with stable claudication were measured for ankle pressure (AP), ankle-brachial index (ABI), PTS, maximal speed (Smax) on treadmill. Daily walking sessions at a speed 20-30% below PTS were prescribed. Determination of the training speed was supervised and facilitated at home. The program included a daily record of exercise data and symptoms, an intermediate PTS re-evaluation to adjust the training speed, and the reassessment of all the parameters after 120 days. RESULTS: Overall patients showed a reduction of systemic blood pressure (151.3+/-14.3 to 147.6+/-18.3 mmHg; 77.1 +/-9.1 to 72.4+/-8, p=0.008) while AP did not. ABI increased from 0.65+/-0.13 to 0.71+/- 0.18 (p=0.01). PTS and Smax rose from 3.2+/-1.1 to 4.2+/-1.5 km/h (p=0.0001) and from 3.9+/-1.3 to 4.6+/-1.3 km/h (p=0.0001), respectively. According to their compliance, patients were divided into 3 groups: 1) trained (T, n=14): exercise at the prescribed speed, 2) free-walkers (FW, n=7): walking speed markedly below PTS and 3) untrained (U, n=8): incomplete program compliance. T group showed symptom reduction up to pain disappearance. The ABI change (0.72+/-0.09 to 0.82+/- 0.16, p<0.02) was correlated to AP increase (r= 0.879). PTS and Smax rose from 3.6+/-1.1 to 5.4+/-0.8 km/h (p<0.02) and from 4.7+/-1.2 to 5.7+/-0.7 (p<0.02), respectively. FW showed improvement of all parameters, and U a better walking efficiency. CONCLUSIONS: In patients with claudication, a low-cost home-based program driven by PTS allows dramatic improvements of functional parameters.


Asunto(s)
Prueba de Esfuerzo/métodos , Terapia por Ejercicio/métodos , Claudicación Intermitente/rehabilitación , Umbral del Dolor/fisiología , Autocuidado/métodos , Anciano , Velocidad del Flujo Sanguíneo/fisiología , Ejercicio Físico/fisiología , Femenino , Humanos , Claudicación Intermitente/diagnóstico por imagen , Claudicación Intermitente/fisiopatología , Masculino , Reproducibilidad de los Resultados , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía Doppler
20.
Int J Sports Med ; 24(5): 352-8, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12868046

RESUMEN

In recent years, some international sports federations have introduced blood testing procedures that can lead to suspension from competition for athletes whose haematologic values exceed certain established limits. In 1994 the International Biathlon Union initiated a three-phase blood testing program to safeguard athletes' health and ensure fair competition. The first phase, lasting three years, was aimed at measuring the haematocrit values of biathletes in order to determine statistically acceptable limits for participation in competition. The second phase, lasting four years, consisted of pre-race testing for an increasing number of athletes and suspension from competition for those whose haematocrit values exceeded 52 % for males and 48 % for females. The results of this second phase (third phase now in progress) are reported. Progressive increases have been made in the numbers of countries examined, athletes tested, and tests performed. This retrospective study reveals a reassuring trend in average values for haematocrit and haemoglobin in the entire study population, a minimal number of athletes with excessive values and a consequent low risk of false positive results, an acceptable incidence of relatively high values (50 % for males and 45 % for females), and constant non-elevated haematological profiles for elite athletes. The variability in individual haematocrit levels among all biathletes with a minimum of four observations during the four-year period is also evaluated and discussed.


Asunto(s)
Doping en los Deportes , Hematócrito/estadística & datos numéricos , Hemoglobinas/análisis , Femenino , Humanos , Masculino , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA